HEADER OXIDOREDUCTASE 26-MAY-10 2XFU TITLE HUMAN MONOAMINE OXIDASE B WITH TRANYLCYPROMINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMINE OXIDASE [FLAVIN-CONTAINING] B; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: MONOAMINE OXIDASE TYPE B,MAO-B; COMPND 5 EC: 1.4.3.4; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAOB; SOURCE 6 EXPRESSION_SYSTEM: KOMAGATAELLA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922 KEYWDS FLAVOPROTEIN, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR C.BINDA,M.LI,F.HUBALEK,N.RESTELLI,D.E.EDMONDSON,A.MATTEVI REVDAT 5 20-DEC-23 2XFU 1 COMPND LINK REVDAT 4 17-OCT-18 2XFU 1 TITLE COMPND SOURCE JRNL REVDAT 4 2 1 DBREF REVDAT 3 24-NOV-10 2XFU 1 REMARK REVDAT 2 06-OCT-10 2XFU 1 REMARK SITE REVDAT 1 09-JUN-10 2XFU 0 SPRSDE 09-JUN-10 2XFU 1OJB JRNL AUTH D.BONIVENTO,E.M.MILCZEK,G.R.MCDONALD,C.BINDA,A.HOLT, JRNL AUTH 2 D.E.EDMONDSON,A.MATTEVI JRNL TITL POTENTIATION OF LIGAND BINDING THROUGH COOPERATIVE EFFECTS JRNL TITL 2 IN MONOAMINE OXIDASE B. JRNL REF J. BIOL. CHEM. V. 285 36849 2010 JRNL REFN ESSN 1083-351X JRNL PMID 20855894 JRNL DOI 10.1074/JBC.M110.169482 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH D.BONIVENTO,E.M.MILCZEK,G.R.MCDONALD,C.BINDA,A.HOLT, REMARK 1 AUTH 2 D.E.EDMONDSON,A.MATTEVI REMARK 1 TITL POTENTIATION OF LIGAND BINDING THROUGH COOPERATIVE EFFECTS REMARK 1 TITL 2 IN MONOAMINE OXIDASE B. REMARK 1 REF J.BIOL.CHEM. V. 285 36849 2010 REMARK 1 REFN ISSN 0021-9258 REMARK 1 PMID 20855894 REMARK 1 DOI 10.1074/JBC.M110.169482 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 14.99 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 62170 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.189 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.239 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.600 REMARK 3 FREE R VALUE TEST SET COUNT : 1629 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.20 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.26 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4493 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.89 REMARK 3 BIN R VALUE (WORKING SET) : 0.2660 REMARK 3 BIN FREE R VALUE SET COUNT : 104 REMARK 3 BIN FREE R VALUE : 0.3140 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7911 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 126 REMARK 3 SOLVENT ATOMS : 405 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.08000 REMARK 3 B22 (A**2) : -0.05000 REMARK 3 B33 (A**2) : -0.03000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.228 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.196 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.135 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.316 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.905 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8245 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 11193 ; 1.256 ; 1.988 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 991 ; 5.780 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 358 ;35.085 ;23.520 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1408 ;16.027 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 58 ;17.435 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1219 ; 0.080 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 6194 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4942 ; 0.543 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 8008 ; 1.089 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 3301 ; 1.877 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 3185 ; 3.107 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2XFU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-MAY-10. REMARK 100 THE DEPOSITION ID IS D_1290044077. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 64040 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.200 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.13000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.20 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.32 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.47000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1OJB REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 6.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z REMARK 290 7555 -X+1/2,Y+1/2,-Z REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 65.30450 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 111.27550 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 65.30450 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 111.27550 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 65.30450 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 111.27550 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 65.30450 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 111.27550 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4980 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 36500 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 2 REMARK 465 PHE A 502 REMARK 465 SER A 503 REMARK 465 ALA A 504 REMARK 465 THR A 505 REMARK 465 ALA A 506 REMARK 465 LEU A 507 REMARK 465 GLY A 508 REMARK 465 PHE A 509 REMARK 465 LEU A 510 REMARK 465 ALA A 511 REMARK 465 HIS A 512 REMARK 465 LYS A 513 REMARK 465 ARG A 514 REMARK 465 GLY A 515 REMARK 465 LEU A 516 REMARK 465 LEU A 517 REMARK 465 VAL A 518 REMARK 465 ARG A 519 REMARK 465 VAL A 520 REMARK 465 SER B 2 REMARK 465 GLY B 497 REMARK 465 LEU B 498 REMARK 465 THR B 499 REMARK 465 THR B 500 REMARK 465 ILE B 501 REMARK 465 PHE B 502 REMARK 465 SER B 503 REMARK 465 ALA B 504 REMARK 465 THR B 505 REMARK 465 ALA B 506 REMARK 465 LEU B 507 REMARK 465 GLY B 508 REMARK 465 PHE B 509 REMARK 465 LEU B 510 REMARK 465 ALA B 511 REMARK 465 HIS B 512 REMARK 465 LYS B 513 REMARK 465 ARG B 514 REMARK 465 GLY B 515 REMARK 465 LEU B 516 REMARK 465 LEU B 517 REMARK 465 VAL B 518 REMARK 465 ARG B 519 REMARK 465 VAL B 520 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 501 CG1 CG2 CD1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2170 O HOH A 2172 2.07 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 52 -74.80 65.55 REMARK 500 SER A 59 -49.10 -151.95 REMARK 500 THR A 64 -10.20 75.80 REMARK 500 ALA A 133 65.91 -162.29 REMARK 500 THR A 201 -76.19 -85.62 REMARK 500 ASP A 310 36.34 70.35 REMARK 500 ALA A 346 -122.37 52.48 REMARK 500 GLU A 379 61.41 -118.66 REMARK 500 ASP A 419 -98.16 57.93 REMARK 500 ALA A 424 -147.98 -114.91 REMARK 500 LYS B 52 -68.84 60.10 REMARK 500 SER B 59 -44.56 -148.09 REMARK 500 THR B 64 -9.04 81.45 REMARK 500 ALA B 133 66.17 -164.41 REMARK 500 THR B 201 -74.79 -80.60 REMARK 500 ARG B 233 71.27 -119.36 REMARK 500 HIS B 252 13.80 81.93 REMARK 500 ALA B 346 -122.09 54.72 REMARK 500 GLU B 379 64.62 -118.80 REMARK 500 SER B 394 -56.09 -124.12 REMARK 500 ASP B 419 -99.41 48.96 REMARK 500 ALA B 424 -146.41 -109.37 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 FLAVIN ADENINE DINUCLEOTIDE (FA8): IN BOTH CHAIN A AND REMARK 600 CHAIN B, THE C4A ATOM OF THE FA8 MOLECULE IS COVALENTLY REMARK 600 BOUND TO THE CAK ATOM OF TRANYLCYPROMINE REMARK 600 TRANYLCYPROMINE DERIVATIVE (3PL): THE TRANYLCYPROMINE REMARK 600 INHIBITOR REACTS WITH THE FA8 COFACTOR OF THE PROTEIN REMARK 600 FORMING A COVALENT ADDUCT. IN BOTH CHAIN A AND CHAIN B THE REMARK 600 CAK ATOM OF THE TRANYLCYPROMINE DERIVATIVE IS BOUND TO THE REMARK 600 C4A ATOM OF FA8. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN A OF RESIDUES 600 TO 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B OF RESIDUES 600 TO 601 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2C67 RELATED DB: PDB REMARK 900 MAO INHIBITION BY RASAGILINE ANALOGUES REMARK 900 RELATED ID: 1S3E RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH 6-HYDROXY-N-PROPARGYL-1(R) REMARK 900 -AMINOINDAN REMARK 900 RELATED ID: 2C73 RELATED DB: PDB REMARK 900 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: REMARK 900 STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS REMARK 900 RELATED ID: 2V60 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR 7- REMARK 900 (3-CHLOROBENZYLOXY )-4-CARBOXALDEHYDE-COUMARIN REMARK 900 RELATED ID: 1OJ9 RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 1,4-DIPHENYL-2-BUTENE REMARK 900 RELATED ID: 2VZ2 RELATED DB: PDB REMARK 900 HUMAN MAO B IN COMPLEX WITH MOFEGILINE REMARK 900 RELATED ID: 1OJD RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH LAURYLDIMETHYLAMINE-N- REMARK 900 OXIDE (LDAO) REMARK 900 RELATED ID: 1S3B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-METHYL-N-PROPARGYL-1(R)- REMARK 900 AMINOINDAN REMARK 900 RELATED ID: 2C66 RELATED DB: PDB REMARK 900 MAO INHIBITION BY RASAGILINE ANALOGUES REMARK 900 RELATED ID: 2XFO RELATED DB: PDB REMARK 900 TRANYLCYPROMINE-INHIBITED HUMAN MONOAMINE OXIDASE B ILE199ALA REMARK 900 MUTANT IN COMPLEX WITH 2-(2-BENZOFURANYL)-2-IMIDAZOLINE REMARK 900 RELATED ID: 2BK5 RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B: I199F MUTANT IN COMPLEX WITH ISATIN REMARK 900 RELATED ID: 1H8R RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE TYPE B (TRUNCATED) REMARK 900 RELATED ID: 2C70 RELATED DB: PDB REMARK 900 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: REMARK 900 STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS REMARK 900 RELATED ID: 2XFN RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2-BENZOFURANYL)-2- REMARK 900 IMIDAZOLINE REMARK 900 RELATED ID: 2BK3 RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH FARNESOL REMARK 900 RELATED ID: 2C76 RELATED DB: PDB REMARK 900 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: REMARK 900 STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS REMARK 900 RELATED ID: 2VRL RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN MAO B IN COMPLEX WITH BENZYLHYDRAZINE REMARK 900 RELATED ID: 1OJA RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH ISATIN REMARK 900 RELATED ID: 2V5Z RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR REMARK 900 SAFINAMIDE REMARK 900 RELATED ID: 2BYB RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH DEPRENYL REMARK 900 RELATED ID: 2VRM RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN MAO B IN COMPLEX WITH PHENYETHYLHYDRAZINE REMARK 900 RELATED ID: 2C65 RELATED DB: PDB REMARK 900 MAO INHIBITION BY RASAGILINE ANALOGUES REMARK 900 RELATED ID: 2XCG RELATED DB: PDB REMARK 900 TRANYLCYPROMINE-INHIBITED HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH REMARK 900 2-(2- BENZOFURANYL)-2-IMIDAZOLINE REMARK 900 RELATED ID: 2C64 RELATED DB: PDB REMARK 900 MAO INHIBITION BY RASAGILINE ANALOGUES REMARK 900 RELATED ID: 2XFP RELATED DB: PDB REMARK 900 ISATIN-INHIBITED HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2- REMARK 900 BENZOFURANYL)-2- IMIDAZOLINE REMARK 900 RELATED ID: 2BK4 RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B: I199F MUTANT IN COMPLEX WITH RASAGILINE REMARK 900 RELATED ID: 2C75 RELATED DB: PDB REMARK 900 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: REMARK 900 STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS REMARK 900 RELATED ID: 2V61 RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN MAO B IN COMPLEX WITH THE SELECTIVE INHIBITOR 7- REMARK 900 (3-CHLOROBENZYLOXY )-4-(METHYLAMINO)METHYL-COUMARIN REMARK 900 RELATED ID: 1S2Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(S)- REMARK 900 AMINOINDAN REMARK 900 RELATED ID: 2C72 RELATED DB: PDB REMARK 900 FUNCTIONAL ROLE OF THE AROMATIC CAGE IN HUMAN MONOAMINE OXIDASE B: REMARK 900 STRUCTURES AND CATALYTIC PROPERTIES OF TYR435 MUTANT PROTEINS REMARK 900 RELATED ID: 1GOS RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B REMARK 900 RELATED ID: 1S2Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MAOB IN COMPLEX WITH N-PROPARGYL-1(R)- REMARK 900 AMINOINDAN (RASAGILINE) REMARK 900 RELATED ID: 2XFQ RELATED DB: PDB REMARK 900 RASAGILINE-INHIBITED HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH 2-(2- REMARK 900 BENZOFURANYL)-2- IMIDAZOLINE REMARK 900 RELATED ID: 1OJC RELATED DB: PDB REMARK 900 HUMAN MONOAMINE OXIDASE B IN COMPLEX WITH N-(2-AMINOETHYL)-P- REMARK 900 CHLOROBENZAMIDE DBREF 2XFU A 2 520 UNP P27338 AOFB_HUMAN 2 520 DBREF 2XFU B 2 520 UNP P27338 AOFB_HUMAN 2 520 SEQRES 1 A 519 SER ASN LYS CYS ASP VAL VAL VAL VAL GLY GLY GLY ILE SEQRES 2 A 519 SER GLY MET ALA ALA ALA LYS LEU LEU HIS ASP SER GLY SEQRES 3 A 519 LEU ASN VAL VAL VAL LEU GLU ALA ARG ASP ARG VAL GLY SEQRES 4 A 519 GLY ARG THR TYR THR LEU ARG ASN GLN LYS VAL LYS TYR SEQRES 5 A 519 VAL ASP LEU GLY GLY SER TYR VAL GLY PRO THR GLN ASN SEQRES 6 A 519 ARG ILE LEU ARG LEU ALA LYS GLU LEU GLY LEU GLU THR SEQRES 7 A 519 TYR LYS VAL ASN GLU VAL GLU ARG LEU ILE HIS HIS VAL SEQRES 8 A 519 LYS GLY LYS SER TYR PRO PHE ARG GLY PRO PHE PRO PRO SEQRES 9 A 519 VAL TRP ASN PRO ILE THR TYR LEU ASP HIS ASN ASN PHE SEQRES 10 A 519 TRP ARG THR MET ASP ASP MET GLY ARG GLU ILE PRO SER SEQRES 11 A 519 ASP ALA PRO TRP LYS ALA PRO LEU ALA GLU GLU TRP ASP SEQRES 12 A 519 ASN MET THR MET LYS GLU LEU LEU ASP LYS LEU CYS TRP SEQRES 13 A 519 THR GLU SER ALA LYS GLN LEU ALA THR LEU PHE VAL ASN SEQRES 14 A 519 LEU CYS VAL THR ALA GLU THR HIS GLU VAL SER ALA LEU SEQRES 15 A 519 TRP PHE LEU TRP TYR VAL LYS GLN CYS GLY GLY THR THR SEQRES 16 A 519 ARG ILE ILE SER THR THR ASN GLY GLY GLN GLU ARG LYS SEQRES 17 A 519 PHE VAL GLY GLY SER GLY GLN VAL SER GLU ARG ILE MET SEQRES 18 A 519 ASP LEU LEU GLY ASP ARG VAL LYS LEU GLU ARG PRO VAL SEQRES 19 A 519 ILE TYR ILE ASP GLN THR ARG GLU ASN VAL LEU VAL GLU SEQRES 20 A 519 THR LEU ASN HIS GLU MET TYR GLU ALA LYS TYR VAL ILE SEQRES 21 A 519 SER ALA ILE PRO PRO THR LEU GLY MET LYS ILE HIS PHE SEQRES 22 A 519 ASN PRO PRO LEU PRO MET MET ARG ASN GLN MET ILE THR SEQRES 23 A 519 ARG VAL PRO LEU GLY SER VAL ILE LYS CYS ILE VAL TYR SEQRES 24 A 519 TYR LYS GLU PRO PHE TRP ARG LYS LYS ASP TYR CYS GLY SEQRES 25 A 519 THR MET ILE ILE ASP GLY GLU GLU ALA PRO VAL ALA TYR SEQRES 26 A 519 THR LEU ASP ASP THR LYS PRO GLU GLY ASN TYR ALA ALA SEQRES 27 A 519 ILE MET GLY PHE ILE LEU ALA HIS LYS ALA ARG LYS LEU SEQRES 28 A 519 ALA ARG LEU THR LYS GLU GLU ARG LEU LYS LYS LEU CYS SEQRES 29 A 519 GLU LEU TYR ALA LYS VAL LEU GLY SER LEU GLU ALA LEU SEQRES 30 A 519 GLU PRO VAL HIS TYR GLU GLU LYS ASN TRP CYS GLU GLU SEQRES 31 A 519 GLN TYR SER GLY GLY CYS TYR THR THR TYR PHE PRO PRO SEQRES 32 A 519 GLY ILE LEU THR GLN TYR GLY ARG VAL LEU ARG GLN PRO SEQRES 33 A 519 VAL ASP ARG ILE TYR PHE ALA GLY THR GLU THR ALA THR SEQRES 34 A 519 HIS TRP SER GLY TYR MET GLU GLY ALA VAL GLU ALA GLY SEQRES 35 A 519 GLU ARG ALA ALA ARG GLU ILE LEU HIS ALA MET GLY LYS SEQRES 36 A 519 ILE PRO GLU ASP GLU ILE TRP GLN SER GLU PRO GLU SER SEQRES 37 A 519 VAL ASP VAL PRO ALA GLN PRO ILE THR THR THR PHE LEU SEQRES 38 A 519 GLU ARG HIS LEU PRO SER VAL PRO GLY LEU LEU ARG LEU SEQRES 39 A 519 ILE GLY LEU THR THR ILE PHE SER ALA THR ALA LEU GLY SEQRES 40 A 519 PHE LEU ALA HIS LYS ARG GLY LEU LEU VAL ARG VAL SEQRES 1 B 519 SER ASN LYS CYS ASP VAL VAL VAL VAL GLY GLY GLY ILE SEQRES 2 B 519 SER GLY MET ALA ALA ALA LYS LEU LEU HIS ASP SER GLY SEQRES 3 B 519 LEU ASN VAL VAL VAL LEU GLU ALA ARG ASP ARG VAL GLY SEQRES 4 B 519 GLY ARG THR TYR THR LEU ARG ASN GLN LYS VAL LYS TYR SEQRES 5 B 519 VAL ASP LEU GLY GLY SER TYR VAL GLY PRO THR GLN ASN SEQRES 6 B 519 ARG ILE LEU ARG LEU ALA LYS GLU LEU GLY LEU GLU THR SEQRES 7 B 519 TYR LYS VAL ASN GLU VAL GLU ARG LEU ILE HIS HIS VAL SEQRES 8 B 519 LYS GLY LYS SER TYR PRO PHE ARG GLY PRO PHE PRO PRO SEQRES 9 B 519 VAL TRP ASN PRO ILE THR TYR LEU ASP HIS ASN ASN PHE SEQRES 10 B 519 TRP ARG THR MET ASP ASP MET GLY ARG GLU ILE PRO SER SEQRES 11 B 519 ASP ALA PRO TRP LYS ALA PRO LEU ALA GLU GLU TRP ASP SEQRES 12 B 519 ASN MET THR MET LYS GLU LEU LEU ASP LYS LEU CYS TRP SEQRES 13 B 519 THR GLU SER ALA LYS GLN LEU ALA THR LEU PHE VAL ASN SEQRES 14 B 519 LEU CYS VAL THR ALA GLU THR HIS GLU VAL SER ALA LEU SEQRES 15 B 519 TRP PHE LEU TRP TYR VAL LYS GLN CYS GLY GLY THR THR SEQRES 16 B 519 ARG ILE ILE SER THR THR ASN GLY GLY GLN GLU ARG LYS SEQRES 17 B 519 PHE VAL GLY GLY SER GLY GLN VAL SER GLU ARG ILE MET SEQRES 18 B 519 ASP LEU LEU GLY ASP ARG VAL LYS LEU GLU ARG PRO VAL SEQRES 19 B 519 ILE TYR ILE ASP GLN THR ARG GLU ASN VAL LEU VAL GLU SEQRES 20 B 519 THR LEU ASN HIS GLU MET TYR GLU ALA LYS TYR VAL ILE SEQRES 21 B 519 SER ALA ILE PRO PRO THR LEU GLY MET LYS ILE HIS PHE SEQRES 22 B 519 ASN PRO PRO LEU PRO MET MET ARG ASN GLN MET ILE THR SEQRES 23 B 519 ARG VAL PRO LEU GLY SER VAL ILE LYS CYS ILE VAL TYR SEQRES 24 B 519 TYR LYS GLU PRO PHE TRP ARG LYS LYS ASP TYR CYS GLY SEQRES 25 B 519 THR MET ILE ILE ASP GLY GLU GLU ALA PRO VAL ALA TYR SEQRES 26 B 519 THR LEU ASP ASP THR LYS PRO GLU GLY ASN TYR ALA ALA SEQRES 27 B 519 ILE MET GLY PHE ILE LEU ALA HIS LYS ALA ARG LYS LEU SEQRES 28 B 519 ALA ARG LEU THR LYS GLU GLU ARG LEU LYS LYS LEU CYS SEQRES 29 B 519 GLU LEU TYR ALA LYS VAL LEU GLY SER LEU GLU ALA LEU SEQRES 30 B 519 GLU PRO VAL HIS TYR GLU GLU LYS ASN TRP CYS GLU GLU SEQRES 31 B 519 GLN TYR SER GLY GLY CYS TYR THR THR TYR PHE PRO PRO SEQRES 32 B 519 GLY ILE LEU THR GLN TYR GLY ARG VAL LEU ARG GLN PRO SEQRES 33 B 519 VAL ASP ARG ILE TYR PHE ALA GLY THR GLU THR ALA THR SEQRES 34 B 519 HIS TRP SER GLY TYR MET GLU GLY ALA VAL GLU ALA GLY SEQRES 35 B 519 GLU ARG ALA ALA ARG GLU ILE LEU HIS ALA MET GLY LYS SEQRES 36 B 519 ILE PRO GLU ASP GLU ILE TRP GLN SER GLU PRO GLU SER SEQRES 37 B 519 VAL ASP VAL PRO ALA GLN PRO ILE THR THR THR PHE LEU SEQRES 38 B 519 GLU ARG HIS LEU PRO SER VAL PRO GLY LEU LEU ARG LEU SEQRES 39 B 519 ILE GLY LEU THR THR ILE PHE SER ALA THR ALA LEU GLY SEQRES 40 B 519 PHE LEU ALA HIS LYS ARG GLY LEU LEU VAL ARG VAL HET FA8 A 600 53 HET 3PL A 601 10 HET FA8 B 600 53 HET 3PL B 601 10 HETNAM FA8 [[(2R,3S,4S)-5-[(4AS)-7,8-DIMETHYL-2,4-DIOXO-4A,5- HETNAM 2 FA8 DIHYDROBENZO[G]PTERIDIN-10-YL]-2,3,4-TRIHYDROXY- HETNAM 3 FA8 PENTOXY]-HYDROXY-PHOSPHORYL] [(2R,3S,4R,5R)-5-(6- HETNAM 4 FA8 AMINOPURIN-9-YL)-3,4-DIHYDROXY-OXOLAN-2-YL]METHYL HETNAM 5 FA8 HYDROGEN PHOSPHATE HETNAM 3PL 3-PHENYLPROPANAL FORMUL 3 FA8 2(C27 H35 N9 O15 P2) FORMUL 4 3PL 2(C9 H10 O) FORMUL 7 HOH *405(H2 O) HELIX 1 1 GLY A 13 SER A 26 1 14 HELIX 2 2 GLN A 65 LEU A 75 1 11 HELIX 3 3 ASN A 108 ARG A 127 1 20 HELIX 4 4 ALA A 133 ALA A 137 5 5 HELIX 5 5 LEU A 139 ASN A 145 1 7 HELIX 6 6 THR A 147 CYS A 156 1 10 HELIX 7 7 THR A 158 THR A 174 1 17 HELIX 8 8 SER A 181 CYS A 192 1 12 HELIX 9 9 GLY A 194 SER A 200 1 7 HELIX 10 10 SER A 214 GLY A 226 1 13 HELIX 11 11 PRO A 265 ILE A 272 5 8 HELIX 12 12 PRO A 279 ILE A 286 1 8 HELIX 13 13 PRO A 304 LYS A 309 1 6 HELIX 14 14 ALA A 346 ALA A 353 1 8 HELIX 15 15 THR A 356 LEU A 372 1 17 HELIX 16 16 SER A 374 GLU A 379 5 6 HELIX 17 17 CYS A 389 GLU A 391 5 3 HELIX 18 18 GLY A 405 GLY A 411 1 7 HELIX 19 19 ARG A 412 LEU A 414 5 3 HELIX 20 20 GLY A 425 ALA A 429 5 5 HELIX 21 21 TYR A 435 MET A 454 1 20 HELIX 22 22 PRO A 458 ILE A 462 5 5 HELIX 23 23 THR A 480 LEU A 486 1 7 HELIX 24 24 SER A 488 THR A 500 1 13 HELIX 25 25 GLY B 13 SER B 26 1 14 HELIX 26 26 GLN B 65 LEU B 75 1 11 HELIX 27 27 ASN B 108 ARG B 127 1 20 HELIX 28 28 ALA B 133 ALA B 137 5 5 HELIX 29 29 LEU B 139 ASN B 145 1 7 HELIX 30 30 THR B 147 CYS B 156 1 10 HELIX 31 31 THR B 158 THR B 174 1 17 HELIX 32 32 SER B 181 GLN B 191 1 11 HELIX 33 33 GLY B 194 SER B 200 1 7 HELIX 34 34 SER B 214 GLY B 226 1 13 HELIX 35 35 PRO B 265 ILE B 272 5 8 HELIX 36 36 PRO B 279 ILE B 286 1 8 HELIX 37 37 PRO B 304 LYS B 309 5 6 HELIX 38 38 ALA B 346 ALA B 353 1 8 HELIX 39 39 THR B 356 GLY B 373 1 18 HELIX 40 40 SER B 374 GLU B 379 5 6 HELIX 41 41 CYS B 389 GLU B 391 5 3 HELIX 42 42 GLY B 405 GLY B 411 1 7 HELIX 43 43 ARG B 412 LEU B 414 5 3 HELIX 44 44 GLY B 425 ALA B 429 5 5 HELIX 45 45 TYR B 435 MET B 454 1 20 HELIX 46 46 PRO B 458 ILE B 462 5 5 HELIX 47 47 THR B 480 LEU B 486 1 7 HELIX 48 48 SER B 488 LEU B 495 1 8 SHEET 1 AA 5 VAL A 229 LYS A 230 0 SHEET 2 AA 5 VAL A 30 LEU A 33 1 O VAL A 32 N LYS A 230 SHEET 3 AA 5 VAL A 7 VAL A 10 1 O VAL A 7 N VAL A 31 SHEET 4 AA 5 TYR A 259 SER A 262 1 O TYR A 259 N VAL A 8 SHEET 5 AA 5 ILE A 421 PHE A 423 1 O TYR A 422 N SER A 262 SHEET 1 AB 2 THR A 45 LEU A 46 0 SHEET 2 AB 2 VAL A 54 ASP A 55 -1 O VAL A 54 N LEU A 46 SHEET 1 AC 3 TYR A 60 VAL A 61 0 SHEET 2 AC 3 ARG A 208 PHE A 210 -1 O ARG A 208 N VAL A 61 SHEET 3 AC 3 THR A 79 LYS A 81 -1 O TYR A 80 N LYS A 209 SHEET 1 AD 7 LYS A 95 PHE A 99 0 SHEET 2 AD 7 ARG A 87 VAL A 92 -1 O LEU A 88 N PHE A 99 SHEET 3 AD 7 TYR A 311 ILE A 317 1 N CYS A 312 O ARG A 87 SHEET 4 AD 7 TYR A 326 ASP A 329 -1 O THR A 327 N MET A 315 SHEET 5 AD 7 ALA A 339 LEU A 345 -1 O MET A 341 N LEU A 328 SHEET 6 AD 7 VAL A 294 TYR A 300 -1 O ILE A 295 N ILE A 344 SHEET 7 AD 7 HIS A 382 ASN A 387 -1 O HIS A 382 N TYR A 300 SHEET 1 AE 4 MET A 254 ALA A 257 0 SHEET 2 AE 4 VAL A 245 THR A 249 -1 O VAL A 245 N ALA A 257 SHEET 3 AE 4 VAL A 235 ASP A 239 -1 N ILE A 236 O GLU A 248 SHEET 4 AE 4 HIS A 273 ASN A 275 1 O HIS A 273 N ILE A 238 SHEET 1 BA 5 VAL B 229 LYS B 230 0 SHEET 2 BA 5 VAL B 30 LEU B 33 1 O VAL B 32 N LYS B 230 SHEET 3 BA 5 VAL B 7 VAL B 10 1 O VAL B 7 N VAL B 31 SHEET 4 BA 5 TYR B 259 SER B 262 1 O TYR B 259 N VAL B 8 SHEET 5 BA 5 ILE B 421 PHE B 423 1 O TYR B 422 N SER B 262 SHEET 1 BB 2 THR B 45 LEU B 46 0 SHEET 2 BB 2 VAL B 54 ASP B 55 -1 O VAL B 54 N LEU B 46 SHEET 1 BC 3 TYR B 60 VAL B 61 0 SHEET 2 BC 3 ARG B 208 PHE B 210 -1 O ARG B 208 N VAL B 61 SHEET 3 BC 3 THR B 79 LYS B 81 -1 O TYR B 80 N LYS B 209 SHEET 1 BD 7 LYS B 95 PHE B 99 0 SHEET 2 BD 7 ARG B 87 VAL B 92 -1 O LEU B 88 N PHE B 99 SHEET 3 BD 7 TYR B 311 ILE B 317 1 N CYS B 312 O ARG B 87 SHEET 4 BD 7 TYR B 326 ASP B 329 -1 O THR B 327 N MET B 315 SHEET 5 BD 7 ALA B 339 LEU B 345 -1 O MET B 341 N LEU B 328 SHEET 6 BD 7 VAL B 294 TYR B 300 -1 O ILE B 295 N ILE B 344 SHEET 7 BD 7 HIS B 382 ASN B 387 -1 O HIS B 382 N TYR B 300 SHEET 1 BE 4 MET B 254 ALA B 257 0 SHEET 2 BE 4 VAL B 245 THR B 249 -1 O VAL B 245 N ALA B 257 SHEET 3 BE 4 VAL B 235 ASP B 239 -1 N ILE B 236 O GLU B 248 SHEET 4 BE 4 HIS B 273 ASN B 275 1 O HIS B 273 N ILE B 238 LINK SG CYS A 397 C8M FA8 A 600 1555 1555 1.61 LINK C4X FA8 A 600 CB 3PL A 601 1555 1555 1.57 LINK SG CYS B 397 C8M FA8 B 600 1555 1555 1.61 LINK C4X FA8 B 600 CB 3PL B 601 1555 1555 1.57 CISPEP 1 ASN A 275 PRO A 276 0 -2.85 CISPEP 2 CYS A 397 TYR A 398 0 4.80 CISPEP 3 ASN B 275 PRO B 276 0 -1.26 CISPEP 4 CYS B 397 TYR B 398 0 3.18 SITE 1 AC1 41 GLY A 11 GLY A 13 ILE A 14 SER A 15 SITE 2 AC1 41 LEU A 33 GLU A 34 ALA A 35 ARG A 36 SITE 3 AC1 41 GLY A 40 GLY A 41 ARG A 42 THR A 43 SITE 4 AC1 41 GLY A 57 GLY A 58 SER A 59 TYR A 60 SITE 5 AC1 41 CYS A 172 TYR A 188 GLN A 206 ARG A 233 SITE 6 AC1 41 PRO A 234 VAL A 235 ALA A 263 ILE A 264 SITE 7 AC1 41 TRP A 388 TYR A 393 CYS A 397 TYR A 398 SITE 8 AC1 41 GLY A 425 THR A 426 GLY A 434 TYR A 435 SITE 9 AC1 41 MET A 436 ALA A 439 HOH A2001 HOH A2175 SITE 10 AC1 41 HOH A2176 HOH A2177 HOH A2178 HOH A2179 SITE 11 AC1 41 HOH A2180 SITE 1 AC2 43 VAL B 10 GLY B 11 GLY B 13 ILE B 14 SITE 2 AC2 43 SER B 15 LEU B 33 GLU B 34 ALA B 35 SITE 3 AC2 43 ARG B 36 GLY B 40 GLY B 41 ARG B 42 SITE 4 AC2 43 THR B 43 GLY B 57 GLY B 58 SER B 59 SITE 5 AC2 43 TYR B 60 CYS B 172 TYR B 188 GLN B 206 SITE 6 AC2 43 ARG B 233 PRO B 234 VAL B 235 ALA B 263 SITE 7 AC2 43 ILE B 264 TRP B 388 TYR B 393 CYS B 397 SITE 8 AC2 43 TYR B 398 GLY B 425 THR B 426 GLY B 434 SITE 9 AC2 43 TYR B 435 MET B 436 ALA B 439 HOH B2032 SITE 10 AC2 43 HOH B2127 HOH B2139 HOH B2185 HOH B2222 SITE 11 AC2 43 HOH B2223 HOH B2224 HOH B2225 CRYST1 130.609 222.551 86.201 90.00 90.00 90.00 C 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007656 0.000000 0.000000 0.00000 SCALE2 0.000000 0.004493 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011601 0.00000 MTRIX1 1 -0.528000 -0.497000 -0.688000 139.34427 1 MTRIX2 1 -0.501000 -0.472000 0.725000 206.99162 1 MTRIX3 1 -0.686000 0.728000 0.001000 -54.59018 1